Tekla Life Sciences Investors Fiscal Q3 2026 Earnings | StockRay
StockRay
T
Tekla Life Sciences Investors
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2026
(ET)
Revenue Growth Trajectory
+164%
YoY
Last 7 quarters
$48M
3/23
9/23
3/24
9/24
3/25
9/25
3/26
Back to stock page
